Company Filing History:
Years Active: 2012
Title: Duncan Cochrane: Innovator in IL-18 Receptor Antigen Binding Proteins
Introduction
Duncan Cochrane is a notable inventor based in Granta Park, GA. He has made significant contributions to the field of biotechnology, particularly in the development of IL-18 receptor antigen binding proteins. His work has implications for diagnosing and treating diseases mediated by the IL-18 receptor.
Latest Patents
Cochrane holds a patent for IL-18 receptor antigen binding proteins. This patent includes polynucleotides encoding the proteins, expression vectors, and host cells for their production. The patent also outlines compositions and methods for diagnosing and treating diseases associated with the IL-18 receptor.
Career Highlights
Duncan Cochrane is currently employed at Amgen Inc., a leading biotechnology company. His innovative work has positioned him as a key figure in the development of therapeutic solutions targeting the IL-18 receptor.
Collaborations
Cochrane has collaborated with notable colleagues, including Dirk E Smith and John Ernest Sims. Their combined expertise has contributed to advancements in their field.
Conclusion
Duncan Cochrane's contributions to the development of IL-18 receptor antigen binding proteins highlight his role as an influential inventor in biotechnology. His work continues to pave the way for new diagnostic and therapeutic methods.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.